These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8976282)

  • 1. The genetic and bacteriological aspects of Peyronie's disease.
    Ralph DJ; Schwartz G; Moore W; Pryor JP; Ebringer A; Bottazzo GF
    J Urol; 1997 Jan; 157(1):291-4. PubMed ID: 8976282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an immunogenetic basis for Peyronie's disease?
    Leffell MS
    J Urol; 1997 Jan; 157(1):295-7. PubMed ID: 8976283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology.
    Nachtsheim DA; Rearden A
    J Urol; 1996 Oct; 156(4):1330-4. PubMed ID: 8808864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques.
    Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM
    J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?
    Rompel R; Weidner W; Mueller-Eckhardt G
    Tissue Antigens; 1991 Sep; 38(3):104-6. PubMed ID: 1796451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease.
    Hauck EW; Hauptmann A; Haag SM; Bohnert A; Weidner W; Bein G; Hackstein H
    Eur Urol; 2004 Nov; 46(5):623-8; discussion 628. PubMed ID: 15474273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any association between Peyronie's disease and serum collagen markers?
    Rhoden EL; Buselato LG; Ting HY; Telöken C; Souto CA
    Int J Impot Res; 2000 Dec; 12(6):302-4. PubMed ID: 11416832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in Peyronie's disease.
    Rompel R; Mueller-Eckhardt G; Schroeder-Printzen I; Weidner W
    Urol Int; 1994; 52(1):34-7. PubMed ID: 8140677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peyronie's disease: a newly recognized autosomal-dominant trait.
    Bias WB; Nyberg LM; Hochberg MC; Walsh PC
    Am J Med Genet; 1982 Jun; 12(2):227-35. PubMed ID: 6213155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunological features of Peyronie's disease.
    Ralph DJ; Mirakian R; Pryor JP; Bottazzo GF
    J Urol; 1996 Jan; 155(1):159-62. PubMed ID: 7490821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27.
    Schiellerup P; Krogfelt KA; Locht H
    J Rheumatol; 2008 Mar; 35(3):480-7. PubMed ID: 18203313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor expression in Peyronie's disease.
    Mulhall JP; Thom J; Lubrano T; Shankey TV
    J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peyronie's disease: a review.
    Gholami SS; Gonzalez-Cadavid NF; Lin CS; Rajfer J; Lue TF
    J Urol; 2003 Apr; 169(4):1234-41. PubMed ID: 12629334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.
    Nyberg LM; Bias WB; Hochberg MC; Walsh PC
    J Urol; 1982 Jul; 128(1):48-51. PubMed ID: 6980996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    J Urol; 2003 Jul; 170(1):281-4. PubMed ID: 12796706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic findings in Peyronie's disease: a controlled study.
    Schiavino D; Sasso F; Nucera E; Alcini E; Gulino G; Milani A; Patriarca G
    Urology; 1997 Nov; 50(5):764-8. PubMed ID: 9372889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
    Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
    J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.
    Hauck EW; Hauptmann A; Weidner W; Bein G; Hackstein H
    J Urol; 2003 Oct; 170(4 Pt 1):1443-6. PubMed ID: 14501786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.